Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Frontiers in Oncology
|
August 26, 2024
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination
Elisa Zanini, Nicole Forster-Gross, Felix Bachmann, et al.
The FEBS Journal
|
January 20, 2021
Pharmacological validation of TDO as a target for Parkinson's disease
Paula Perez-Pardo, Yvonne Grobben, Nicole Willemsen-Seegers, et al.
Frontiers in Immunology
|
February 15, 2021
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
Yvonne Grobben, Jos de Man, Antoon M van Doornmalen, et al.
Journal of Hepatology
|
September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
MMWR. Morbidity and Mortality Weekly Report
|
January 31, 2014
Strengthening global health security capacity--Vietnam demonstration project, 2013
Phu Dac Tran, Long Ngoc Vu, Hien Tran Nguyen, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis
Jian Liu, Deodial Guiadeen, Arto Krikorian, et al.
Protein Science : a Publication of the Protein Society
|
February 4, 2005
Protein folding: defining a "standard" set of experimental conditions and a preliminary kinetic data set of two-state proteins
Karen L Maxwell, David Wildes, Arash Zarrine-Afsar, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Frontiers in Oncology
|
August 26, 2024
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination
Elisa Zanini, Nicole Forster-Gross, Felix Bachmann, et al.
The FEBS Journal
|
January 20, 2021
Pharmacological validation of TDO as a target for Parkinson's disease
Paula Perez-Pardo, Yvonne Grobben, Nicole Willemsen-Seegers, et al.
Frontiers in Immunology
|
February 15, 2021
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
Yvonne Grobben, Jos de Man, Antoon M van Doornmalen, et al.
Journal of Hepatology
|
September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
MMWR. Morbidity and Mortality Weekly Report
|
January 31, 2014
Strengthening global health security capacity--Vietnam demonstration project, 2013
Phu Dac Tran, Long Ngoc Vu, Hien Tran Nguyen, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis
Jian Liu, Deodial Guiadeen, Arto Krikorian, et al.
Protein Science : a Publication of the Protein Society
|
February 4, 2005
Protein folding: defining a "standard" set of experimental conditions and a preliminary kinetic data set of two-state proteins
Karen L Maxwell, David Wildes, Arash Zarrine-Afsar, et al.
Page
of 3